(Q43785600)

26 November 2017

title

Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? (English)

1 reference

26 November 2017

1 reference

2

1 reference

26 November 2017

Dario Giugliano

3

0 references

author name string

Katherine Esposito

series ordinal

1

1 reference

26 November 2017

publication date

12 March 2013

1 reference

26 November 2017

1 reference

26 November 2017

volume

44

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

343-345

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-013-9918-x

26 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

American diabetes association-European association for the study of diabetes position statement: due diligence was conducted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Is glycemic control improving in U.S. adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Standards of medical care in diabetes--2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

When metformin fails in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Optimal management of type 2 diabetes: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

HbA1c targets for type 2 diabetes: How many, …how far!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-9918-X

On patient need, equity, supplier-induced demand, and the need to assess the outcome of common medical practices

21 January 2018

1 reference

12 December 2020

Clinical inertia as a clinical safeguard

1 reference

12 December 2020

Shared decision making--pinnacle of patient-centered care

1 reference

12 December 2020

Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors

1 reference

12 December 2020

Comparing adherence and persistence across 6 chronic medication classes

1 reference

12 December 2020

10.1007/S12020-013-9918-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1019993223

0 references

1 reference